Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania

被引:0
|
作者
Mwaka A. Kakolwa
Muhidin K. Mahende
Deus S. Ishengoma
Celine I. Mandara
Billy Ngasala
Erasmus Kamugisha
Johannes B. Kataraihya
Renata Mandike
Sigsbert Mkude
Frank Chacky
Ritha Njau
Zul Premji
Martha M. Lemnge
Marian Warsame
Didier Menard
Abdunoor M. Kabanywanyi
机构
[1] Ifakara Health Institute,National Institute for Medical Research
[2] Tanga Research Centre,Department of Parasitology, School of Public Health
[3] Muhimbili University of Health and Allied Sciences,undefined
[4] Catholic University of Health and Allied Sciences/Bugando Medical Centre,undefined
[5] National Malaria Control Programme (NMCP),undefined
[6] World Health Organization Country Office,undefined
[7] Aga Khan University Hospital,undefined
[8] Gothenburg University,undefined
[9] Institut Pasteur,undefined
来源
关键词
Artemisinin-based combination therapy; Efficacy; Safety; Malaria; Molecular markers; Artemisinin; Piperaquine; Tanzania;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Challenges of artemisinin-based combination therapy roll out in Africa
    Kamya, M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 : 14 - 14
  • [32] Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
    André Daher
    Ghait Aljayyoussi
    Dhelio Pereira
    Marcus V. G. Lacerda
    Márcia A. A. Alexandre
    Cristiana T. Nascimento
    Júlio Castro Alves
    Laís Bastos da Fonseca
    Diego Medeiros Dias da Silva
    Douglas Pereira Pinto
    Danielle Fonseca Rodrigues
    Ana Carolina Rios Silvino
    Taís Nóbrega de Sousa
    Cristiana Ferreira Alves de Brito
    Feiko O. ter Kuile
    David G. Lalloo
    Malaria Journal, 18
  • [33] From chloroquine to artemisinin-based combination therapy: the Sudanese experience
    Malik, E. M.
    Mohamed, T. A.
    Elmardi, K. A.
    Mowien, R. M.
    Elhassan, A. H.
    Elamin, S. B.
    Mannan, A. A.
    Ahmed, E. S.
    MALARIA JOURNAL, 2006, 5 (1)
  • [34] Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa
    Djimde, Moussa
    Kayentao, Kassoum
    Tshiongo, Japhet Kabalu
    Fofana, Bakary
    Arama, Charles
    Sirima, Sodiomon B.
    Ouedraogo, Jean Bosco
    Beavogui, Abdoul Habib
    Sagara, Issaka
    Dicko, Alassane
    Mens, Petra F.
    Schallig, Henk D. F. H.
    Djimde, Abdoulaye
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (09): : 1337 - 1345
  • [35] Metabolism is not a Major Contributor to the Toxicity of Piperaquine, a Long-acting Antimalarial Agent in Artemisinin-based Combination Therapy
    Zhang, Liyuan
    Liu, Zhaohua
    Zhang, Yunrui
    Xie, Yuewu
    Xing, Jie
    CURRENT DRUG METABOLISM, 2021, 22 (10) : 824 - 834
  • [36] Artemisinin-based Combination Therapy (ACT) in the treatment of Malaria in pregnancy
    Elahi, Ayesha
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 : 91 - 91
  • [37] Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
    van der Pluijm, Rob W.
    Peto, Thomas J.
    Hamaluba, Mainga
    Callery, James J.
    Tripura, Rupam
    White, Nicholas J.
    Dondorp, Arjen M.
    LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 765 - 766
  • [38] SAFETY AND TOLERABILITY PROFILE OF ARTEMISININ-BASED ANTIMALARIAL COMBINATION THERAPY (ACT) IN ADULT NIGERIANS
    Ayinbuomwan, S.
    Isah, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 86 - 87
  • [39] Subsidising artemisinin-based combination therapy in the private retail sector
    Opiyo, Newton
    Yamey, Gavin
    Garner, Paul
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (03):
  • [40] Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
    Xu, Chengchao
    Wong, Yin Kwan
    Liao, Fu Long
    Jiang, Tingliang
    Wang, Jigang
    Tu, Youyou
    LANCET INFECTIOUS DISEASES, 2022, 22 (05): : 585 - 586